Loading...
•
Sep 30, 2025
Teva Q3 2025 Earnings Report
Teva's innovative portfolio drove its 11th consecutive quarter of growth in Q3 2025, leading to an increased 2025 outlook for Austedo® and Non-GAAP EPS.
Key Takeaways
Teva reported strong third-quarter 2025 results, with revenues reaching $4.5 billion, a 3% increase year-over-year. The growth was primarily fueled by its innovative portfolio, particularly AUSTEDO®, which saw a 38% increase in U.S. revenue. The company also raised its 2025 revenue outlook for AUSTEDO® and its non-GAAP EPS guidance, reflecting confidence in its 'Pivot to Growth' strategy and pipeline advancements.
Teva's revenues for Q3 2025 reached $4.5 billion, marking an increase of 3% year-over-year.
The innovative portfolio, including AUSTEDO®, AJOVY®, and UZEDY®, collectively grew by approximately 33% in local currency year-over-year.
AUSTEDO® global revenues were $618 million, a 38% increase in local currency, leading to an upward revision of its 2025 revenue outlook.
Non-GAAP operating income margin improved to 28.9%, demonstrating progress towards the 30% target by 2027.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teva has updated its full-year 2025 outlook, tightening the revenue range and increasing the low-end of non-GAAP operating income, adjusted EBITDA, and non-GAAP diluted EPS, while maintaining free cash flow guidance.
Positive Outlook
- Increased 2025 revenue outlook for AUSTEDO® to $2,050 million - $2,150 million.
- Raised the low-end of non-GAAP operating income guidance to $4.4 billion - $4.6 billion.
- Increased the low-end of adjusted EBITDA guidance to $4.8 billion - $5.0 billion.
- Non-GAAP diluted EPS outlook raised to $2.55 - $2.65.
- Reaffirmed 2025 revenue outlooks for AJOVY® ($630 million - $640 million) and UZEDY® ($190 million - $200 million).
Challenges Ahead
- Tightened the high-end of the overall revenue outlook by $200 million to $16.8 billion - $17.0 billion.
- Exclusive discussions for the TAPI sale have terminated, requiring a renewed sales process.
- Foreign exchange remains a volatile factor that can negatively impact revenue and income.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...